Albanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Financial Incentives for Homeless Smokers: A Community-based RCT

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
Lidhja ruhet në kujtesën e fragmenteve
StatusiNuk është ende rekrutimi
Sponsorët
Massachusetts General Hospital
Bashkëpunëtorë
National Cancer Institute (NCI)
National Institutes of Health (NIH)

Fjalë kyçe

Abstrakt

This community-based randomized controlled trial will test the effect of contingent financial rewards on smoking abstinence among homeless-experienced adult cigarette smokers. Participants will be recruited from 3 Boston Health Care for the Homeless Program (BHCHP) locations - a shelter clinic, a day center, and a medical center clinic. All participants will receive free transdermal nicotine patches and in-person tobacco coaching. In addition, incentive arm participants will receive financial rewards for biochemically-verified smoking abstinence. Embedded qualitative interviews will explore the mechanisms of on-treatment and post-treatment effects of financial incentives on smoking abstinence in the context of homelessness.

Përshkrim

Homeless people have a 3.5-fold higher prevalence of cigarette smoking in comparison to non-homeless people, contributing to 2-fold higher rates of lung cancer and 3- to 5-fold higher rates of tobacco-attributable death. Homeless smokers want to quit, but studies have not yet uncovered the optimal approach to help them do so. In an 8-week pilot randomized controlled trial (RCT) at Boston Health Care for the Homeless Program (BHCHP), we found that financial incentives for smoking abstinence were associated with 7-fold higher odds of brief smoking abstinence in comparison to a non-incentivized control condition. These results suggest that financial incentives are a promising approach for reducing smoking in this vulnerable population, but further investigation in a larger sample is needed to improve the duration of on-treatment abstinence, assess post-treatment effects, and better understand mechanisms of action and contextual factors that may influence treatment response.

To address these gaps, we will conduct a community-based RCT of financial incentives for smoking abstinence among adult smokers at BHCHP. We will recruit 400 participants from 3 BHCHP sites and randomize them to receive guideline-concordant standard care with (N=200) or without (N=200) financial incentives for smoking abstinence. Standard care will consist of 12 weeks of nicotine replacement therapy (NRT) and 5 sessions with a tobacco coach who will provide behavioral counseling, distribute NRT, and coordinate referrals to existing tobacco treatment resources. Incentive arm participants will additionally receive a 24-week schedule of 20 debit card payments contingent on short-term abstinence based on exhaled carbon monoxide levels, augmented with 16 interspersed payments contingent on longer-term abstinence based on urine anabasine levels. We will use an embedded-experiment mixed methods design, where qualitative data collection is embedded within a larger quantitative RCT with the following aims:

Aim 1. To determine the effect of the financial incentives intervention on anabasine-verified 7-day smoking abstinence at A) the end of treatment (24 weeks) and B) 24 weeks after treatment (48 weeks).

We hypothesize that incentive arm participants will have greater abstinence at both timepoints.

Aim 2. To assess why, how, and under what circumstances homeless smokers A) achieve abstinence in response to financial incentives and B) maintain abstinence after incentives are stopped.

To accomplish this aim, we will interview selected participants at 24 and 48 weeks, probing cognitive, procedural, and contextual dimensions of their response to financial incentives to generate hypotheses about mechanisms for on-treatment and post-treatment effects and to inform future work in this area.

Datat

Verifikuar së fundmi: 05/31/2020
Paraqitur së pari: 06/21/2020
Regjistrimi i vlerësuar u dorëzua: 06/21/2020
Postuar së pari: 06/23/2020
Përditësimi i fundit i paraqitur: 06/21/2020
Përditësimi i fundit i postuar: 06/23/2020
Data e fillimit të studimit aktual: 08/31/2020
Data e vlerësuar e përfundimit primar: 08/31/2023
Data e vlerësimit të përfundimit të studimit: 05/31/2024

Gjendja ose sëmundja

Tobacco Smoking
Smoking Cessation
Homelessness
Financial Incentives

Ndërhyrja / trajtimi

Behavioral: Financial Rewards (N=200)

Drug: Transdermal nicotine patch (12 weeks)

Behavioral: In-person smoking cessation counseling

Faza

-

Grupet e krahëve

KrahNdërhyrja / trajtimi
Active Comparator: Control (N=200)
Transdermal nicotine patch In-person smoking cessation counseling
Experimental: Financial Rewards (N=200)
Transdermal nicotine patch In-person smoking cessation counseling Contingent financial rewards for smoking abstinence
Behavioral: Financial Rewards (N=200)
Escalating financial rewards for smoking abstinence, verified by exhale carbon monoxide <5ppm Escalating financial rewards for smoking abstinence, verified by urine anabasine levels <2ng/ml

Kriteret e pranimit

Moshat e pranueshme për studim 18 Years Për të 18 Years
Gjinitë e pranueshme për studimAll
Pranon Vullnetarë të Shëndetshëmpo
Kriteret

Inclusion Criteria:

- Age ≥18 years old

- Lifetime smoker of ≥100 cigarettes with current daily smoking of ≥5 cigarettes per day, verified by an exhaled carbon monoxide level of ≥8 ppm

- Ready to try quitting smoking within the next 6 months

- Proficient in English

- Currently or formerly homeless

Exclusion Criteria:

- Unable to provide informed consent

Rezultati

Masat Kryesore të Rezultateve

1. Anabasine-verified 7-day smoking abstinence at 24 weeks [24 weeks]

Point-prevalent smoking abstinence, defined as self-report of not smoking in the past 7 days and verified by a urine anabasine level <2 ng/ml.

Masat dytësore të rezultateve

1. Anabasine-verified 7-day smoking abstinence at 48 weeks [48 weeks]

Point-prevalent smoking abstinence, defined as self-report of not smoking in the past 7 days and verified by a urine anabasine level <2 ng/ml.

Masat e tjera të rezultateve

1. Anabasine-verified 7-day smoking abstinence at 12 weeks [12 weeks]

Point-prevalent smoking abstinence, defined as self-report of not smoking in the past 7 days and verified by a urine anabasine level <2 ng/ml.

2. Anabasine-verified 7-day smoking abstinence at 36 weeks [36 weeks]

Point-prevalent smoking abstinence, defined as self-report of not smoking in the past 7 days and verified by a urine anabasine level <2 ng/ml.

Bashkohuni në faqen
tonë në facebook

Baza e të dhënave më e plotë e bimëve medicinale e mbështetur nga shkenca

  • Punon në 55 gjuhë
  • Kurime bimore të mbështetura nga shkenca
  • Njohja e bimëve nga imazhi
  • Harta GPS interaktive - etiketoni bimët në vendndodhje (së shpejti)
  • Lexoni botime shkencore në lidhje me kërkimin tuaj
  • Kërkoni bimë medicinale nga efektet e tyre
  • Organizoni interesat tuaja dhe qëndroni në azhurnim me kërkimet e lajmeve, provat klinike dhe patentat

Shkruani një simptomë ose një sëmundje dhe lexoni në lidhje me barërat që mund të ndihmojnë, shtypni një barishte dhe shikoni sëmundjet dhe simptomat që përdoren kundër.
* I gjithë informacioni bazohet në kërkimin shkencor të botuar

Google Play badgeApp Store badge